US Patent 7449189 Glycoconjugate vaccines for use in immune-compromised populations
Patent 7449189 was granted and assigned to Nabi Biopharmaceuticals on November, 2008 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7449189 Glycoconjugate vaccines for use in immune-compromised populations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
